Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Other3

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT05257395Phase 3Active Not Recruiting
A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
Advanced Breast Cancer
PrincipalinvestigatorStart date: 2022-03-14
NCT04297995Phase 2Unknown
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
Head and Neck Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2020-07-29
NCT06433362Phase 2Unknown
CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
Studydirector

Research Network

Collaboration Network

8 collaborators·22 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The Second Affiliated Hospital of Harbin Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckLymphoma, T-Cell, Peripheral
Similarity Score20%

Yan Sun

Peking University Cancer Hospital & Institute

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Shanghai Henlius Biotech
Collaborated on 1 trial
Similarity Score14%

Shubin Wang

Peking University Shenzhen Hospital

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Shanghai Henlius Biotech
Collaborated on 1 trial
Similarity Score14%

Guangyuan Hu

Tongji Hospital

Related
2 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Shanghai Henlius Biotech
Collaborated on 1 trial
Similarity Score14%

Meiyu Fang

Zhejiang Cancer Hospital

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Shanghai Henlius Biotech
Collaborated on 1 trial
Similarity Score14%

Ye Guo, PhD

Shanghai East Hospital

Related
2 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Shanghai Henlius Biotech
Collaborated on 1 trial
Similarity Score14%

Huilai Zhang

Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital

Related
2 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral

Worked with same sponsors:

Tianjin Medical University Cancer Institute and Hospital
Collaborated on 1 trial
Similarity Score14%

Guochun Cao

Jiangsu Cancer Institute & Hospital

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Shanghai Henlius Biotech
Collaborated on 1 trial
Similarity Score14%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score10%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Advanced Breast Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05257395Phase 3PrincipalInvestigator

A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer

Advanced Breast Cancer
Active Not Recruiting
NCT04297995Phase 2PrincipalInvestigator

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

Head and Neck Squamous Cell Carcinoma
Unknown
NCT06433362Phase 2StudyDirector

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

Peripheral T Cell Lymphoma
Unknown

All 3 trials loaded